Pacific Biosciences

$15.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.89 (+6.12%) Today
+$0.54 (+3.50%) As of 4:54 AM EST after-hours

Why Robinhood?

You can buy or sell PACB and other stocks, options, and ETFs commission-free!

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. The listed name for PACB is Pacific Biosciences of California, Inc. Common Stock.

CEO
Christian O. Henry
Employees
404
Headquarters
Menlo Park, California
Founded
2000
Market Cap
2.89B
Price-Earnings Ratio
Dividend Yield
Average Volume
2.78M
High Today
$15.63
Low Today
$14.45
Open Price
$14.61
Volume
2.33M
52 Week High
$17.14
52 Week Low
$2.20

Collections

PACB Earnings

-$0.20
-$0.13
-$0.06
$0.01
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 4, After Hours

You May Also Like